AVTE Chart
- 52-Week Range: $0.00 - $0.00
- Market Capitalization: $288.78M
- Short Percentage: 0%
- Target Price: $23.75
- Shares Outstanding: 24.41M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
AVTE released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Aerovate Therapeutics Announces Third Quarter 2021 Financial ResultsGlobeNewsWire | November 15th
- Aerovate Therapeutics Announces Its Addition to the Russell 2000® IndexGlobeNewsWire | September 17th
- Aerovate Therapeutics Announces Second Quarter 2021 Financial ResultsGlobeNewsWire | August 16th
- Aerovate Therapeutics Announces Pricing of Upsized Initial Public OfferingGlobeNewsWire | June 29th
Company Info
Website: https://aerovatetx.com
Address: 930 Winter Street, Waltham, MA, United States, 02116
Sector: Healthcare
Industry: Biotechnology
Full time employees: 16
Address: 930 Winter Street, Waltham, MA, United States, 02116
Sector: Healthcare
Industry: Biotechnology
Full time employees: 16
$AVTE you wanna be a successful trader close your trades green
$AVTE good times
$AVTE has just been halted from trading due to volatility.
$AVTE has just been halted from trading due to volatility.
$AVTE hmm...
$AVTE day trade is ok to buy here but sell later
$AVTE has just been halted from trading due to volatility.
$AVTE has just been halted from trading due to volatility.
$AVTE has just been halted from trading due to volatility.
$AVTE whats the news????